The Effect of Metformin on Low Birth Weight Girls with Precocious Puberty: A Protocol for Systematic Review and Meta-analysis

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2022 Jul 1

PMID 35776991

Authors

Zhiheng Lin

Xiaohui Sui

Lijuan Li

Ying Wang

Junde Zhao

Affiliations

Soon will be listed here.

Abstract

Background: In recent years, the role of metformin in girls with precocious puberty (PP) has been increasingly frequently studied. The objective of this present study is to assess the effect of metformin on low birth weight girls with precocious puberty (LBW-PP girls).

Methods: We search the confirmed studies about circulating metformin and PP from the databases of EMBASE, PubMed, and Web of Science. Data were reported as weighted mean difference (WMD) and associated 95% confidence intervals (CIs). Analysis was performed by Review Manager 5.3 and Stata version 12.0.

Results: A total of 205 cases (metformin group n = 102, untreated group n = 103) were included in this study. The meta-analysis of randomized controlled trials (RCTs) suggested that metformin had statistically significant effects on testosterone (P = .001), androstenedione (P = .022), bone mineral density (BMD; P = .151), triglycerides (P ≤ .001), body mass index Z score (BMI Z score; P ≤ .001), dehydroepiandrosterone-sulfate (DHEAS; P = .053), sex hormone-binding globulin (SHBG; P = .049), high-density lipoprotein (HDL) cholesterol (P ≤ .001), low-density lipoprotein (LDL) cholesterol (P = .021), fat mass (P ≤ .001), lean mass (P = .025), and fasting insulin (P = .002).

Conclusion: This meta-analysis provided evidence of the efficacy of metformin in girls with LBW-PP girls, which proved that metformin could improve metabolism and reduce weight. Metformin had a positive effect on preventing LBW-PP girls from developing into obesity and polycystic ovarian syndrome. In addition, this meta-analysis provided important reference opinions and directions for the treatment of LBW-PP girls.

Citing Articles

A META analysis and systematic review of the effects of exercise interventions on middle-aged and elderly patients with depression.

Zhang Z, Liu J, Zhu K, Huo G PLoS One. 2025; 20(1):e0303594.

PMID: 39787100 PMC: 11717248. DOI: 10.1371/journal.pone.0303594.

References

Toumba M, Hadjidemetriou A, Topouzi M, Savva S, Demetriadou R, Kanaris C . Evaluation of the auxological and metabolic status in prepubertal children born small for gestational age. J Pediatr Endocrinol Metab. 2005; 18(7):677-88. DOI: 10.1515/jpem.2005.18.7.677. View

Willemsen R, Elleri D, Williams R, Ong K, Dunger D . Pros and cons of GnRHa treatment for early puberty in girls. Nat Rev Endocrinol. 2014; 10(6):352-63. DOI: 10.1038/nrendo.2014.40. View

Pernicova I, Korbonits M . Metformin--mode of action and clinical implications for diabetes and cancer. Nat Rev Endocrinol. 2014; 10(3):143-56. DOI: 10.1038/nrendo.2013.256. View

Patel R, Shah G . Effect of metformin on clinical, metabolic and endocrine outcomes in women with polycystic ovary syndrome: a meta-analysis of randomized controlled trials. Curr Med Res Opin. 2017; 33(9):1545-1557. DOI: 10.1080/03007995.2017.1279597. View

Ohara M, Yoshida-Komiya H, Ono-Okutsu M, Yamaguchi-Ito A, Takahashi T, Fujimori K . Metformin reduces androgen receptor and upregulates homeobox A10 expression in uterine endometrium in women with polycystic ovary syndrome. Reprod Biol Endocrinol. 2021; 19(1):77. PMC: 8165781. DOI: 10.1186/s12958-021-00765-6. View

Ibanez L, Ferrer A, Ong K, Amin R, Dunger D, de Zegher F . Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome. J Pediatr. 2004; 144(1):23-9. DOI: 10.1016/j.jpeds.2003.08.015. View

Ibanez L, Valls C, Marcos M, Ong K, Dunger D, de Zegher F . Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and postpubertal discontinuation of metformin treatment. J Clin Endocrinol Metab. 2004; 89(9):4331-7. DOI: 10.1210/jc.2004-0463. View

Palomba S, Falbo A, Zullo F, Orio Jr F . Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review. Endocr Rev. 2008; 30(1):1-50. DOI: 10.1210/er.2008-0030. View

Ibanez L, Lopez-Bermejo A, Callejo J, Torres A, Cabre S, Dunger D . Polycystic ovaries in nonobese adolescents and young women with ovarian androgen excess: relation to prenatal growth. J Clin Endocrinol Metab. 2007; 93(1):196-9. DOI: 10.1210/jc.2007-1800. View

10.

Ucar A, Yackobovitch-Gavan M, Erol O, Yekeler E, Saka N, Bas F . Associations of size at birth and postnatal catch-up growth status with clinical and biomedical characteristics in prepubertal girls with precocious adrenarche: preliminary results. J Clin Endocrinol Metab. 2014; 99(8):2878-86. DOI: 10.1210/jc.2013-3144. View

11.

Partsch C, Sippell W . Pathogenesis and epidemiology of precocious puberty. Effects of exogenous oestrogens. Hum Reprod Update. 2001; 7(3):292-302. DOI: 10.1093/humupd/7.3.292. View

12.

Bailey C . Metformin: historical overview. Diabetologia. 2017; 60(9):1566-1576. DOI: 10.1007/s00125-017-4318-z. View

13.

Ibanez L, Valls C, Potau N, Marcos M, de Zegher F . Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche. J Clin Endocrinol Metab. 2000; 85(10):3526-30. DOI: 10.1210/jcem.85.10.6908. View

14.

Victor V, Rovira-Llopis S, Banuls C, Diaz-Morales N, Castello R, Falcon R . Effects of metformin on mitochondrial function of leukocytes from polycystic ovary syndrome patients with insulin resistance. Eur J Endocrinol. 2015; 173(5):683-91. DOI: 10.1530/EJE-15-0572. View

15.

Ibanez L, Lopez-Bermejo A, Diaz M, Marcos M, de Zegher F . Metformin treatment for four years to reduce total and visceral fat in low birth weight girls with precocious pubarche. J Clin Endocrinol Metab. 2008; 93(5):1841-5. DOI: 10.1210/jc.2008-0013. View

16.

Lopez-Bermejo A, Diaz M, Moran E, de Zegher F, Ibanez L . A single nucleotide polymorphism in STK11 influences insulin sensitivity and metformin efficacy in hyperinsulinemic girls with androgen excess. Diabetes Care. 2010; 33(7):1544-8. PMC: 2890356. DOI: 10.2337/dc09-1750. View

17.

Ibanez L, Valls C, Ferrer A, Marcos M, de Zegher F . Sensitization to insulin induces ovulation in nonobese adolescents with anovulatory hyperandrogenism. J Clin Endocrinol Metab. 2001; 86(8):3595-8. DOI: 10.1210/jcem.86.8.7756. View

18.

Abreu A, Dauber A, Macedo D, Noel S, Brito V, Gill J . Central precocious puberty caused by mutations in the imprinted gene MKRN3. N Engl J Med. 2013; 368(26):2467-75. PMC: 3808195. DOI: 10.1056/NEJMoa1302160. View

19.

de Zegher F, Garcia Beltran C, Lopez-Bermejo A, Ibanez L . Metformin for Rapidly Maturing Girls with Central Adiposity: Less Liver Fat and Slower Bone Maturation. Horm Res Paediatr. 2017; 89(2):136-140. DOI: 10.1159/000479369. View

20.

Alpanes M, Alvarez-Blasco F, Fernandez-Duran E, Luque-Ramirez M, Escobar-Morreale H . Combined oral contraceptives plus spironolactone compared with metformin in women with polycystic ovary syndrome: a one-year randomized clinical trial. Eur J Endocrinol. 2017; 177(5):399-408. DOI: 10.1530/EJE-17-0516. View